JKL Partners to acquire cosmetics company Perenne Bell Perenne Bell's revenue doubled to $62 mil in 2020
Translated by Kim So-in 공개 2021-09-27 08:01:32
이 기사는 2021년 09월 27일 07:53 thebell 에 표출된 기사입니다.
South Korean private equity (PE) firm JKL Partners will acquire management rights of Perenne Bell, a beauty brand that is creating a great sensation in the Southeast Asian market.JKL Partners is currently in talks to acquire management rights of Perenne Bell in a private deal, industry sources said on Thursday. The deal may complete within this year if the negotiations go smoothly. The deal is expected to be quite sizeable considering the company’s financial performance and growth potential although the exact price tag hasn’t been finalized yet.
Founded in 2016, Perenne Bell operates derma cosmetics brand Some By Mi. The brand ranked second in sales in the cosmetics category at Shopee, the largest e-commerce platform in Southeast Asia.
Thanks to its popularity in the Southeast Asian market, Perenne Bell’s revenue doubled to 72.7 billion won ($62 million) in 2020 from 37.2 billion won in 2019. About 95% of its revenue comes from the overseas markets, including Vietnam, Indonesia, and Malaysia. Its operating profit also grew from 15.7 billion won to 37.2 billion won, with its operating margin standing at 51%.
Perenne Bell is expected to expand its product lines backed by its solid brand awareness. JKL Partners is likely to focus on entering new markets, including the U.S., Japan, and the Middle East.
JKL Partners is making active investments this year. It acquired South Korea's largest laundry service provider Cleantopia for about 180 billion won and invested 80 billion won in budget carrier T’way Air, 100 billion won in Jcontentree, and about 34 billion won in Shinheung SEC. The PE firm is expected to continue its investment spree using its fifth blind-pool fund, which closed at 750 billion won at the end of last year. (Reporting by Se-hun Jo)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- [제일약품의 온코닉테라퓨틱 첫 '신약']세번째 P-CAB '자큐보' 2년만에 신약 명맥 잇는다
- 강동그룹, 디아너스CC 품는다
- [제약사 TSR 분석]제일약품, '주가·실적·배당' 3중고 열쇠 '온코닉의 신약'
- (여자)아이들 우기, 'YUQ1' 아이튠즈 앨범차트 10개국 석권
- 박셀바이오, 진행성 간세포암 타깃 'Vax-NK' 특허 출원
- 베니스 비엔날레, 30년만에 두발로 선 '곽훈'의 의미
- [대기업 프로스포츠 전술전략]'모기업발 숙제' 엔씨다이노스, 당분간 긴축 불가피
- 하이브, '민희진 없는' 어도어 경쟁력 입증할까
- SK 오너가 3세 최성환의 '승부수'
- 어느 수집가의 꿈 '이건희 컬렉션'